Detalles de la búsqueda
1.
Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial.
Gastroenterology
; 157(2): 403-412.e5, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31054846
2.
Rivaroxaban, Aspirin, or Both to Prevent Early Coronary Bypass Graft Occlusion: The COMPASS-CABG Study.
J Am Coll Cardiol
; 73(2): 121-130, 2019 01 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-30654882
3.
Pantoprazole to prevent gastroduodenal events in patients receiving rivaroxaban and/or aspirin in a randomized, double-blind, placebo-controlled trial
Gastroenterology
; 157(2): 403-412, Aug., 2019. tab, graf
Artículo
en Inglés
| SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1022748
4.
A prospective randomized trial comparing image quality, study interpretability, and radiation dose of narrow acquisition window with widened acquisition window protocols in prospectively ECG-triggered coronary computed tomography angiography.
J Cardiovasc Comput Tomogr
; 7(1): 18-24, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23452996
Resultados
1 -
4
de 4
1
Próxima >
>>